Drug Target ReviewCRISPR gives new insight into autoimmune disordersDrug Target ReviewResearchers at The University of California Berkley(UCB) used a tool called CRISPR activation (CRISPRa), developed at The University of California, San Francisco (… Continue reading
Xconomy |
Bio Roundup: CAR–T’s Huge Week, Merck’s ‘Pib Choice & More
Xconomy The far-out idea of reprogramming a patient’s immune cells to fight cancer, known as CAR–T, entered the mainstream this week, and two numbers highlight the tale. The first is $11.9 billion, the price Gilead Sciences is paying for Kite Pharma and its … Gilead’s Acquisition Of Kite Pharma Relieves Shareholders’ EnnuiSeeking Alpha |
New Scientist |
Pioneering gene therapy approved for leukaemia in the US
New Scientist A CAR-T treatment – a type of gene therapy for cancer – has been approved for use in the US. Announced by the US Food and Drug Administration (FDA) on Wednesday, this is the first approval anywhere in the world for a type of CAR-T therapy, although the … US clears breakthrough gene therapy for childhood leukemiaABC News First Gene Therapy Treatment Approved in USSmithsonian FDA approves a ‘historic’ new type of leukemia treatmentToday.com FDA.gov –National Cancer Institute –National Cancer Institute –NPR all 578 news articles » |
|
Barclays Begins Coverage on Editas Medicine, Inc. (EDIT) With A Rating Of “Overweight”
Modern Readers CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |